PDF(Pubmed)
Abstract：
OBJECTIVE: Although comprehensive and widespread guidelines on how to conduct systematic reviews of outcome measurement instruments (OMIs) exist, for example from the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) initiative, key information is often missing in published reports. This article describes the development of an extension of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guideline: PRISMA-COSMIN for OMIs 2024.
METHODS: The development process followed the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) guidelines and included a literature search, expert consultations, a Delphi study, a hybrid workgroup meeting, pilot testing, and an end-of-project meeting, with integrated patient/public involvement.
RESULTS: From the literature and expert consultation, 49 potentially relevant reporting items were identified. Round 1 of the Delphi study was completed by 103 panelists, whereas round 2 and 3 were completed by 78 panelists. After 3 rounds, agreement (≥ 67%) on inclusion and wording was reached for 44 items. Eleven items without consensus for inclusion and/or wording were discussed at a workgroup meeting attended by 24 participants. Agreement was reached for the inclusion and wording of 10 items, and the deletion of 1 item. Pilot testing with 65 authors of OMI systematic reviews further improved the guideline through minor changes in wording and structure, finalized during the end-of-project meeting. The final checklist to facilitate the reporting of full systematic review reports contains 54 (sub)items addressing the review\'s title, abstract, plain language summary, open science, introduction, methods, results, and discussion. Thirteen items pertaining to the title and abstract are also included in a separate abstract checklist, guiding authors in reporting for example conference abstracts.
CONCLUSIONS: PRISMA-COSMIN for OMIs 2024 consists of two checklists (full reports; abstracts), their corresponding explanation and elaboration documents detailing the rationale and examples for each item, and a data flow diagram. PRISMA-COSMIN for OMIs 2024 can improve the reporting of systematic reviews of OMIs, fostering their reproducibility and allowing end-users to appraise the quality of OMIs and select the most appropriate OMI for a specific application. NOTE: In order to encourage its wide dissemination this article is freely accessible on the web sites of the journals: Health and Quality of Life Outcomes; Journal of Clinical Epidemiology; Journal of Patient-Reported Outcomes; Quality of Life Research.
METHODS: The development process followed the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) guidelines and included a literature search, expert consultations, a Delphi study, a hybrid workgroup meeting, pilot testing, and an end-of-project meeting, with integrated patient/public involvement.
RESULTS: From the literature and expert consultation, 49 potentially relevant reporting items were identified. Round 1 of the Delphi study was completed by 103 panelists, whereas round 2 and 3 were completed by 78 panelists. After 3 rounds, agreement (≥ 67%) on inclusion and wording was reached for 44 items. Eleven items without consensus for inclusion and/or wording were discussed at a workgroup meeting attended by 24 participants. Agreement was reached for the inclusion and wording of 10 items, and the deletion of 1 item. Pilot testing with 65 authors of OMI systematic reviews further improved the guideline through minor changes in wording and structure, finalized during the end-of-project meeting. The final checklist to facilitate the reporting of full systematic review reports contains 54 (sub)items addressing the review\'s title, abstract, plain language summary, open science, introduction, methods, results, and discussion. Thirteen items pertaining to the title and abstract are also included in a separate abstract checklist, guiding authors in reporting for example conference abstracts.
CONCLUSIONS: PRISMA-COSMIN for OMIs 2024 consists of two checklists (full reports; abstracts), their corresponding explanation and elaboration documents detailing the rationale and examples for each item, and a data flow diagram. PRISMA-COSMIN for OMIs 2024 can improve the reporting of systematic reviews of OMIs, fostering their reproducibility and allowing end-users to appraise the quality of OMIs and select the most appropriate OMI for a specific application. NOTE: In order to encourage its wide dissemination this article is freely accessible on the web sites of the journals: Health and Quality of Life Outcomes; Journal of Clinical Epidemiology; Journal of Patient-Reported Outcomes; Quality of Life Research.
摘要：
目的：尽管关于如何对结果测量仪器（OMIs）进行系统评价的全面和广泛的指南已经存在，例如，来自COSMIN(基于共识的健康测量指标选择标准)倡议，关键信息通常在已发布的报告中缺失。本文介绍了系统审查和荟萃分析（PRISMA）2020指南的首选报告项目扩展的开发：OMIs2024的PRISMA-COSMIN。
方法：开发过程遵循增强健康研究的质量和透明度（EQUATOR）指南，并包括文献检索，专家咨询,Delphi的一项研究,混合工作组会议，试点测试,和项目结束会议，患者/公众的综合参与。
结果：从文献和专家咨询来看，确定了49个潜在相关的报告项目。德尔菲研究的第一轮由103名小组成员完成，而第2轮和第3轮由78名小组成员完成。经过三轮，就44个项目的纳入和措辞达成一致(≥67%)。在24名与会者参加的工作组会议上，讨论了11个未达成共识的项目和/或措辞。就列入和措辞10个项目达成协议,并删除1个项目。对OMI系统评价的65位作者进行的试点测试通过措辞和结构的微小变化进一步改进了指南。在项目结束会议期间完成。便于报告完整的系统审查报告的最终清单包含54个（分）项目，涉及审查的标题，abstract,简单的语言摘要，开放科学,介绍,方法,结果，和讨论。与标题和摘要有关的十三个项目也包括在单独的摘要清单中，指导作者报告例如会议摘要。
结论：用于2024年OMIs的PRISMA-COSMIN包括两个清单（完整报告；摘要），他们相应的解释和阐述文件，详细说明每个项目的理由和例子，和数据流图。2024年OMIs的PRISMA-COSMIN可以改善OMIs系统评价的报告，促进其可重复性，并允许最终用户评估OMI的质量，并为特定应用选择最合适的OMI。注意：为了鼓励其广泛传播，本文可在以下期刊的网站上免费访问：健康与生活质量结果；临床流行病学杂志；患者报告结果杂志；生活质量研究。
方法：开发过程遵循增强健康研究的质量和透明度（EQUATOR）指南，并包括文献检索，专家咨询,Delphi的一项研究,混合工作组会议，试点测试,和项目结束会议，患者/公众的综合参与。
结果：从文献和专家咨询来看，确定了49个潜在相关的报告项目。德尔菲研究的第一轮由103名小组成员完成，而第2轮和第3轮由78名小组成员完成。经过三轮，就44个项目的纳入和措辞达成一致(≥67%)。在24名与会者参加的工作组会议上，讨论了11个未达成共识的项目和/或措辞。就列入和措辞10个项目达成协议,并删除1个项目。对OMI系统评价的65位作者进行的试点测试通过措辞和结构的微小变化进一步改进了指南。在项目结束会议期间完成。便于报告完整的系统审查报告的最终清单包含54个（分）项目，涉及审查的标题，abstract,简单的语言摘要，开放科学,介绍,方法,结果，和讨论。与标题和摘要有关的十三个项目也包括在单独的摘要清单中，指导作者报告例如会议摘要。
结论：用于2024年OMIs的PRISMA-COSMIN包括两个清单（完整报告；摘要），他们相应的解释和阐述文件，详细说明每个项目的理由和例子，和数据流图。2024年OMIs的PRISMA-COSMIN可以改善OMIs系统评价的报告，促进其可重复性，并允许最终用户评估OMI的质量，并为特定应用选择最合适的OMI。注意：为了鼓励其广泛传播，本文可在以下期刊的网站上免费访问：健康与生活质量结果；临床流行病学杂志；患者报告结果杂志；生活质量研究。
